May, 2006:

Merck admits data error in Vioxx study

Poll: FDA less trustworthy than the industry

Lance fronts cancer coalition clinical trials awareness drive

Medical centers extend ban on gifts to doctors

Product News from News Brief 05/30/06

People News from News Brief 05/30/06

Account Wins from News Brief 05/30/06

FDA approves Merck vaccine to treat shingles

Crawford implicated in decision to block Plan B

TAP settles charges of inflating Lupron price

AstraZeneca to invest $100 million on China research program

Cubist’s Cubicin gets boost from expanded indication

Study claims off-label prescribing not rooted in science

Novartis heads up new malaria drug research partnership

Publishers blast study proposing ban on pharma ads in journals

FDA advisory committee recommends Gardasil approval

GSW named Tamiflu AOR

GlaxoSmithKline extends Garnier’s contract as migraine blockbuster goes OTC in UK

Saxton to head Pfizer CME group

Catlett takes on Euro RSCG Life PR

AstraZeneca to launch Toprol-XL awareness campaign

Product news from the 05/23/06 News Brief

People news from the 05/23/06 News Brief

Company news from the 05/23/06 News Brief

Account wins from the 05/23/06 News Brief

FDA decision to put Indiplon ‘to bed’

More consumers asking docs for specific treatments: Prevention study

J&J to reorganize its pharma business

Rozerem DTC campaign to launch this summer

Pharma reputation improves but still near bottom

Federal government gives $1 billion to manufacturers to speed up avian flu vaccine production

Pfizer gets FDA OK for anti-smoking drug Chantix

McClellan in ‘secret Plan B meeting’

Study says big pharma may be headed for R&D resurgence

HBA honorees share stories and advice

Product news from the 05/16/06 News Brief

People news from the 05/16/06 News Brief

Company news from the 05/16/06 News Brief

37 million enrolled in Rx drug benefit

NEJM sat on Vioxx article warnings for years: WSJ

GlaxoSmithKline issues Paxil warning

Pfizer says Lipitor sales won’t ‘fall off a cliff’

Former FDA commissioner facing criminal investigation

Drug companies get over $1 billion in flu vaccine funding

Vendome to relaunch Postgraduate Medicine

Bristol-Myers Squibb to halt manufacturing of antibiotic Tequin

About Health lands WebMD exec

FDA approves Nexium for treatment of teens

Lilly sees patent woes

Product news from 05/05/06 News Brief

People news from the 05/05/06 News Brief

Account wins from the 05/05/06 News Brief

Company news from the 05/05/06 News Brief

CHC calls for simpler DTC guidelines

FDA alerted on abort drug

Ex-HHS deputy Allen in fraud arrest

Off-label prosecutors target devices

Waxman alleges Troy blocked Plan B decision

DTC spend leveling off, marketers say

Pfizer launches latest Lipitor TV spots

Novartis hit with class-action suit

Structural Graphics picks up print, promotion firm

Abbott, J&J: tops in sales force quality

As I see it

Quadrant shifts to emergency-only

Haymarket launches senior-care title

Harte-Hanks named No. 26 in "Global Outsourcing 100" list

Ryan iDirect names new management supervisor

Regulation: a risky business

Is media outsourcing a good thing?

Edelman adds Karr to its Health Policy

Pharma analysts attuned to the value of reputation

PR View by Beth Herskovits

The pen got too mighty

Medical sites valuable but inconsistent

BMS awards Interlink Emsam interactive work

Antidote

Web Watch

Headliner: Shire's Matthew Emmens

Specialty Journal Ad Review: Floundering Fortunes

FDA at 100: Alumni takes its temperature

IMS Health Report: The Quest for Propulsion

WLF: leave ethics out of approvals